Interleukin-21 in hemodialyzed patients: Association with the etiology of chronic kidney disease and the seropositivity against hepatitis C virus infection

Clinical Biochemistry

Volumn 44, Issue 17-18, 2011, Pages 1416-1420

  Pawlak, Krystyna ^a   Mysliwiec, Michal ^a   Pawlak, Dariusz ^a,b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

Author keywords

Anti HCV seropositivity; Glomerulonephritis; Hemodialysis; IL 21

Indexed keywords

ENOXAPARIN; HEPARIN; INTERLEUKIN 21; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE DISTRIBUTION; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIALYSIS MEMBRANE; DISEASE ASSOCIATION; FEMALE; GLOMERULONEPHRITIS; HEMODIALYSIS PATIENT; HEPATITIS C; HUMAN; IMMUNOREGULATION; INFLAMMATION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PLEIOTROPY; PRIORITY JOURNAL; SEX DIFFERENCE; UREMIA;

AGED; CASE-CONTROL STUDIES; FEMALE; FIBRINOGEN; GLOMERULONEPHRITIS; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INTERLEUKIN-6; INTERLEUKINS; MALE; MIDDLE AGED; PROTHROMBIN; REGRESSION ANALYSIS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 81555228726     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.09.003     Document Type: Article

References (26)

1. Eleftheriadis T., Antoniadi G., Liakopoulos V., Kartsios C., Stefanidis I. Disturbances of acquired immunity in hemodialysis patients. Semin Dial 2007, 20:440-451.
2. Charest A.F., McDougall J., Goldstein M.B. A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients. Am J Kidney Dis 2000, 36:976-982.
3. Propst T., Propst A., Lhotta K., Vogel W., König P. Reinforced intradermal hepatitis B vaccination in hemodialysis patients in superior in antibody response to intramuscular or subcutaneous vaccination. Am J Kidney Dis 1998, 32:1041-1045.
4. Litjens N.H.R., van Druningen C.J., Betjes M.G. Progressive loss of renal function is associated with activation and depletion of naive T lymphocytes. Clin Immunol 2006, 118:83-91.
5. Yoon J.W., Gollapudi S., Pahl M.V., Vaziri N.D. Naive and central memory T-cell lymphopenia in end-stage renal disease. Kidney Int 2006, 70:371-376.
6. Litjens N.H.R., Huisman M., van der Dorpel M., Betjes M.G.H. Impaired immune responses and antigen-specific memory CD4+ T cells in hemodialysis patients. J Am Soc Nephrol 2008, 19:1483-1490.
7. Parrish-Novak J., Dillon S.R., Nelson A., Hammond A., Sprecher C., Gross J.A., et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 2000, 408:57-63.
8. Habib T., Nelson A., Kaushansky K. IL-21: a novel IL-2-family lymphokine that modulates B, T, and natural killer cell responses. J Allergy Clin Immunol 2003, 112:1033-1045.
9. Ettinger R., Sims G.P., Fairhurst A.M., Robbins R., da Silva Y.S., Spolski R., et al. IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J Immunol 2005, 175:7867-7879.
10. Avery D.T., Deenick E.K., Ma C.S., Suryani S., Simpson N., Chew G.Y., et al. B-cell intrinsic signalling through IL-21 receptor and STAT3 is required for establishing long-lived antibody response in humans. J Exp Med 2010, 207:155-171.
11. Costanzo A., Chimenti M.S., Botti E., Caruso R., Sarra M., Monteleone G. IL-21 in the pathogenesis and treatment of skin disease. J Dermatol Sci 2010, 60:61-66.
12. Fewkes N.M., Mackall C.L. Novel gamma-chain cytokines as candidate immune modulators in immune therapies for cancer. Cancer J 2010, 16:392-398.
13. Yi J.S., Cox M.A., Zajac A.J. Interleukin-21: a multifunctional regulator of immunity of infections. Microbes Infect 2010, 12:1111-1119.
14. Sarra M., Franze E., Pallone F., Monteleone G. Targeting interleukin-21 in inflammatory disease. Expert Opin Ther Targets 2011, 15:697-702.
15. Bammens B., Evenepoel P., Verbeke K., Vanrenterghem Y. Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms. Kidney Int 2003, 64:2238-2243.
16. Shemin D., Bostom A.G., Laliberty P., Dworkin L.D. Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis 2001, 38:85-90.
17. Kalman K., Löcsey L., Hauck M., Leövey A. The effect of uraemic "middle-sized molecules" on T lymphocyte function. Int Urol Nephrol 1980, 12:367-374.
18. Navarro J., Contreras P., Touraine J.L., Freyria A.M., Later R., Traeger J. Effect of middle molecules on immunological functions. Artif Organs 1981, 4(Suppl):76-81.
19. Lim W.H., Kireta S., Russ G.R., Coates P.T. Uremia impairs blood dendritic cell function in hemodialysis patients. Kidney Int 2007, 71:1122-1131.
20. Wei L., Laurence A., Elias K.M., O'Shea J.J. Il-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J Biol Chem 2007, 282:34605-34610.
21. Kitching A.R., Holdsworth S.R. The emergence of TH17 cells as effectors of renal injury. J Am Soc Nephrol 2011, 22:235-238.
22. Turner J.E., Paust H.J., Steinmetz O.M., Panzer U. The Th17 immune response in renal inflammation. Kidney Int 2010, 77:1070-1075.
23. Schulze zur Wiesch J., Lauer G.M., Day C.L., Kim A.Y., Ouchi K., Duncan J.E., et al. Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes. J Immunol 2005, 175:3603-3613.
24. Pestka J.M., Zeisel M.B., Bläser E., Schürmann P., Bartosch B., Cosset F.L., et al. Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C. Proc Natl Acad Sci U S A 2007, 104:6025-6030.
25. Watanabe H., Wells F., Major M.E. Clearance of hepatitis C in chimpanzees is associated with intrahepatic T-cell perforin expression during the late acute phase. J Viral Hepat 2010, 17:245-253.
26. Publicover J., Goodsell A., Nishimura S., Vilarinho S., Wang Z., Avanesyan L., et al. IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B. J Clin Invest 2011, 121:1154-1162.